Pancreatic Cancer Research

ResearcherChina Pharmaceutical UniversityNo recent work listed

Pyone Myat Thu

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5069971579. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 1 paper

Papers 2

  1. Sodium cantharidinate, a novel anti-pancreatic cancer agent that activates functional p53. Co-author DOI 10.1007/s11427-019-1753-3↗
  2. Phellodendrine chloride suppresses proliferation of KRAS mutated pancreatic cancer cells through inhibition of nutrients uptake via macropinocytosis. Co-author DOI 10.1016/j.ejphar.2019.01.060↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ji Li · 2 shared papers, 2019–2021 · strength 0.23
  2. Ping Li · 2 shared papers, 2019–2021 · strength 0.23
  3. Xiaojun Xu · 2 shared papers, 2019–2021 · strength 0.23
  4. Xiaoxiao Liu · 1 shared paper, 2021 · strength 0.14
  5. Peng Yang · 1 shared paper, 2021 · strength 0.14
  6. Zu‐Guo Zheng · 1 shared paper, 2019 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.